Disclaimer

The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • 7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • +886-2-77201070
  • info@gravitycapital.com
  • Disclaimer

    The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

    In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • address:
    7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • tel:
    +886-2-77201070
  • email:
    info@gravitycapital.com
  • MALO CLINIC CHINA closed RMB 230 million Series D funding

    Release time: 2018-09-25Number of visits:887author:admin

         One of our portfolio companies, MALO CLINIC CHINA, a chain dental service provider closed an RMB 230million Series D funding jointly invested by V-star Capital, Green Land Capital, and Gopher Asset.

         The proceed of the funding will be used for further expansion of clinics in China through new setups and acquisitions, R&D for new technologies and products, and working capital.

        Founded in 1995 in Portugal,MALO CLINIC is a global dental and oral health service provider dedicated to management of chain dental clinics, and dentistry related product R&D, denture processing, and training. MALO CLINIC CHINA has adopted a “whole industry chain” approach since its commencement in 2012 and now owns 21 dental clinics in 16 cities, 2 denture processing factories, 1 training center and 1 procurement center.

        MALO CLINIC CHINA is plan to invest in further development of dental disciplines of all owned clinics and in establishing a practical training system led by top senior dentists, said by Mr. Yang, COO of MALO CLINIC CHINA.

        As shown by open sources, MALO CLINIC CHINA has previously closed 3 rounds of financing, including round A of ten millions in USD by High Light Capital in April 2014, and round B of 85 million RMB by High Light Capital, HaoYue Capital, Gravity Capital and V-star Capital in April 2016, and round C of 110 million RMB by High Light Capital, Positive Prospects Ltd., GP Capital and V-star Capital in April 2017.